ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

304
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
Refresh
25 May 2018 10:35

FSC Chairman Speaks on Decision Framework

An article in the 24 May issue of BusinessKorea  (link below) reports on a talk given by Financial Services Commission (FSC) Chairman Choi...

Share
13 May 2018 22:45

The Week That Was in North Asia @Smartkarma: Do Donkis Rohm the North Korean Shires?

Firstly, apologies for the terrible string of puns, but the image just sticks in our head.Kospi rose 0.66% for the week while Topix rose 1.32%,...

Logo
Mio Kato
205 Views
Share
13 May 2018 00:21

Last Week in Event SPACE: Samsung Biologics, Shire, Lotte, Mitula, JSW, Nisshinbo

Last Week in Event SPACE ... In what is probably the secondmost interesting arb in the world, the attractive trade may simply be to go long LIFULL...

Logo
245 Views
Share
10 May 2018 04:38

FSS Vs. Samsung BioLogics - Latest Situation Update

Below is how the Samsung BioLogics accounting fraud case will be reviewed and concluded by the FSC. The FSS (Financial Supervisory Service) tables...

Logo
196 Views
Share
bullishGenoray Co Ltd
08 May 2018 12:13

Genoray IPO Preview (Part 2) - Valuation Analysis

We are positive on the Genoray IPO. Our one year price target of the company is 25,944 won, which would represent nearly 27% higher than the high...

Logo
218 Views
Share
x